Medochemie Africa BI
Command Dashboard
Uganda, 2026, through April
Module M1
YTD Revenue
€227,817
50,555 units sold
Annual Target
€796,567
28.6% achieved
Pace vs Linear
-4.7%
4/12 months of data
Active Customers
133
Avg €232.23 / txn
Monthly Revenue
EUR by sale monthPartner Split
YTD revenueBOOTS€134,710
416 transactions€324 avg
LABOREX€93,107
565 transactions€165 avg
By Therapeutic Category
YTD revenueBy Customer Segment
YTD revenueTop Products
Top 10 by YTD revenue| SKU | Category | Revenue YTD | Units | vs Target |
|---|---|---|---|---|
| ARCHIFAR 1G 1'S | ANTI-INFECTIVES | €38,261 | 5,545 | 39.6% |
| MEDAXONUM 2G 10'S | ANTI-INFECTIVES | €25,500 | 850 | 42.5% |
| CEFIMED 400MG | ANTI-INFECTIVES | €24,814 | 6,530 | 54.4% |
| MEDAXONUM 1G | ANTI-INFECTIVES | €14,158 | 7,653 | 38.3% |
| MOXICLAV 625MG | ANTI-INFECTIVES | €13,928 | 3,482 | 99.5% |
| AXETINE 500MG | ANTI-INFECTIVES | €12,902 | 3,258 | 81.5% |
| CEFIMED 200MG | ANTI-INFECTIVES | €12,665 | 3,333 | 51.3% |
| AXETINE 750MG 10'S | ANTI-INFECTIVES | €12,103 | 931 | 133.0% |
| ZEPILEN 1G 10'S | ANTI-INFECTIVES | €11,644 | 803 | 32.1% |
| COTRIM 960MG | ANTI-INFECTIVES | €9,660 | 1,610 | 112.0% |